Exogenous Hormones, Reproductive History, and Breast Cancer
Overview
Authors
Affiliations
We studied 284 patients (20-74 years of age) with carcinoma of the breast and 367 controls; all were admitted to one hospital between 1969 and 1972. The disease was associated with nulliparity, first pregnancy over 20 years of age, premenopausal status, and a lower frequency of artificial menopause. After adjustment for these factors, no significant difference was found between the breast cancer patients and controls in their prior use of either estrogens or oral contraceptives, but the confidence limits on the relative risk, especially for oral contraceptives, were large.
Kanadys W, Baranska A, Malm M, Blaszczuk A, Polz-Dacewicz M, Janiszewska M Int J Environ Res Public Health. 2021; 18(9).
PMID: 33925599 PMC: 8123798. DOI: 10.3390/ijerph18094638.
Hormone replacement therapy and breast cancer. A review of current knowledge.
Bergkvist L, Persson I Drug Saf. 1996; 15(5):360-70.
PMID: 8941497 DOI: 10.2165/00002018-199615050-00006.
Oral contraceptive use and early abortion as risk factors for breast cancer in young women.
Pike M, Henderson B, Casagrande J, Rosario I, Gray G Br J Cancer. 1981; 43(1):72-6.
PMID: 7459241 PMC: 2010485. DOI: 10.1038/bjc.1981.10.
Age at first birth, parity and risk of breast cancer in a Swedish population.
Adami H, Hansen J, Jung B, Rimsten A Br J Cancer. 1980; 42(5):651-8.
PMID: 7459205 PMC: 2010566. DOI: 10.1038/bjc.1980.298.
Brenner P West J Med. 1982; 136(3):211-9.
PMID: 7090370 PMC: 1273648.